title: Management of idiopathic thrombocytopenic purpura in elderly patients.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Andrès
authors.forename: Samira
authors.initials: S
authors.lastname: Daou
authors.forename: Jacques
authors.initials: J
authors.lastname: Zimmer
authors.forename: Laure
authors.initials: L
authors.lastname: Federici
authors.forename: Frédéric
authors.initials: F
authors.lastname: Maloisel
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007239:Infections / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy; D012074:Remission Induction; D013156:Splenectomy
chemical_list: D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D003613:Danazol